| Phase 4 |
| NCT07320105 |
Postoperative Radiotherapy for Postoperative N2 Metastases of NSCLC in the Immunotherapy… |
Non-Small Cell Lung Cancer |
Recruiting |
| NCT07492654 |
Clinical Study on the Prevention and Treatment of Radiation Vaginitis With… |
Vaginitis |
Not Yet Recruiting |
| Phase 3 |
| NCT06095154 |
CTV Delineation Based Solely on Geometric Expansion From GTV in Nasopharyngeal Carcinoma |
Nasopharyngeal Carcinoma by AJCC V8 Stage |
Recruiting |
| NCT06793917 |
Tislelizumab Plus FOLFOX Versus POF in the Treatment of Locally Advanced: a Multicenter… |
Gastric Cancer |
Recruiting |
| NCT07467330 |
Dalpiciclib Combined With Endocrine Therapy and Metronomic Capecitabine vs Dalpiciclib… |
Breast Cancer |
Recruiting |
| NCT06095167 |
Induction Chemotherapy and Immunotherapy Combined Radiotherapy With or Without Concurrent… |
Nasopharyngeal Carcinoma |
Not Yet Recruiting |
| NCT06775756 |
Reducing Dose and Irradiated Volume in Cervical Prophylactic Irradiation for… |
Nasopharyngeal Carcinoma |
Not Yet Recruiting |
| NCT07268690 |
Risk-Adapted Omission of Level Va Irradiation in Nasopharyngeal Carcinoma |
Nasopharyngeal Carcinoma by AJCC V9 Stage |
Not Yet Recruiting |
| NCT07613567 |
A Clinical Study of QL1706 Combined With Chemotherapy as Neoadjuvant Therapy for… |
Locally Advanced Cervical Carcinoma |
Not Yet Recruiting |
| Phase 2/3 |
| NCT05699655 |
Tislelizumab Combined With Apatinib and Oxaliplatin Plus S1 Vs Oxaliplatin Plus S1 as… |
Immunotherapy Gastrict Cancer |
Recruiting |
| Phase 2 |
| NCT05624099 |
Camrelizumab Combined With Chemoradiotherapy in Advanced Esophageal Cancer. |
Esophageal Neoplasms |
Recruiting |
| NCT05753826 |
Adebrelimab Combined With Fuzuloparib in the Treatment of Patients With Recurrent… |
Ovarian Neoplasms |
Recruiting |
| NCT05910177 |
Neoadjuvant Treatment of Neuroendocrine Cervix Carcinomar With Camrelizumab Combined With… |
Carcinoma |
Recruiting |
| NCT06463834 |
A Study of Sintilimab Combined With Chemotherapy for Neoadjuvant Treatment of Esophageal… |
Esophageal Squamous Cell Carcinoma |
Recruiting |
| NCT07055399 |
Neoadjuvant Iparomlimab and Tuvonralimab Plus Chemotherapy-eclipse for Locally Advanced… |
Locally Advanced Cervical Cancer |
Recruiting |
| NCT06787183 |
SCRT(Short Course Radiotherapy) Combined With CAPOX Plus QL1706 for Rectal Cancer Liver… |
Locally Advanced Rectal Cancer With Liver Metastases |
Recruiting |
| NCT07256236 |
SKB264 Plus QL1706 in Recurrent or Metastatic Cervical Cancer |
Cervical Cancer |
Recruiting |
| NCT07581834 |
Efficacy and Safety of Dalpiciclib Combined With Endocrine Adjuvant Therapy for Early HR… |
Breast Diseases |
Recruiting |
| NCT05897138 |
A Study to Evaluate Lenvatinib Plus Tislelizumab for Locally Advanced Unresectable or… |
Hepatocellular Carcinoma |
Not Yet Recruiting |
| NCT05479240 |
Neoadjuvant Chemoradiotherapy Combined With Tislelizumab in the Treatment of Locally… |
Immunotherapy |
Not Yet Recruiting |
| NCT05922358 |
Phase II Study of Reuse of Oxaliplatin Hypersensitivity in Gastrointestinal Tumors |
Gastrointestinal Tumors |
Not Yet Recruiting |
| NCT06149767 |
Clinical Study of Adebrelimab Combined With Concurrent Chemoradiotherapy in Cervical… |
Cervical Cancer |
Not Yet Recruiting |
| NCT06066216 |
Cadonilimab (AK104) Plus Chemotherapy in Patients With Recurrent or Advanced Endometrial… |
Endometrial Cancer |
Not Yet Recruiting |
| NCT06218888 |
A Phase II Clinical Study of the Efficacy and Safety of Tislelizumab Combined With… |
Colo-rectal Cancer |
Not Yet Recruiting |
| NCT06331845 |
Stop and go Strategy as First-line Treatment for Widely Metastatic Nasopharyngeal… |
Metastatic Nasopharyngeal Carcinoma |
Not Yet Recruiting |